Differential (Click to cross reference) algorithm anticonvulsants cerebral infarction cerebrovascular accident cerebrovascular accident, acute management of cerebrovascular accident, complications with cerebrovascular accident, cost of cerebrovascular accident, thrombolytic agents in treatment cerebrovascular accident, work up for cost effectiveness critical pathway diagnosis related group electroencephalogram, video monitoring with epilepsy referral centers fibrinolytic agents fibrinolytic agents, contraindications fibrinolytic agents, utilization fibrinolytic therapy, selection criteria hospital length of stay medical-legal aspects of neurology neurologic consultation neurologic practice patient information and support practice guidelines quality of life review article seizure seizure, diagnosis of seizure, differential diagnosis of seizure, intractable seizure, intractable, treatment of seizure, psychosocial aspects of seizure, treatment of stroke protocol tissue plasminogen activator, intravenous treatment of neurologic disorder

Showing articles 0 to 5 of 5 Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006 The Role of Epilepsy Centers in Delivering Care to Patients with Intractable Epilepsy Neurol 44:1347-1352, Lesser,R.P., 1994 A Model for Management of Patients with Stroke During the Acute Phase Outcome and Economic Implications Stroke 24:1823-1827, Odderson,I.R.&McKenna,B.S., 1993 Neurology, Age, Hospital Costs, and DRGs Neurol 38:655-660, Sands,G.H.,et al, 1988 Hospital Stays by Diagnosis Related Group for Neurologic Patients Treated Medically Neurol 37:139-145, Lagoe,R.J., 1987 Showing articles 0 to 5 of 5